Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.

Mantovani, Luisa

Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study. [electronic resource] - Leukemia & lymphoma Feb 2002 - 265-74 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

1042-8194

10.1080/10428190290006035 doi


Acute Disease
Adolescent
Adult
Algorithms
Cytarabine--administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Parenteral--methods
Leukemia, Myeloid--complications
Male
Middle Aged
Remission Induction--methods
Stem Cell Transplantation
Survival Analysis
Transplantation, Homologous
Treatment Outcome